Faculty, staff and community partners are working together to address community needs — and they’re getting students involved with support from Engaged Opportunity Grants from the Einhorn Center for Community Engagement.
Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute have developed new AI tools tailored to digital pathology, a growing field that uses high-resolution digital images created from tissue samples to help diagnose disease.
Home health aides are vulnerable to stress, isolation and depressive symptoms, which impact their own health as well as their patients’ desire to age in place, according new research.
One in five of the bacterial strains that cause typhoid fever have genetic variations in their external layer, called Vi capsule, that provide higher virulence, higher infectivity and high antibiotic resistance, Cornell researchers have discovered.
A multinational team led by Weill Cornell Medicine investigators developed a test for an HIV strain that disproportionately affects women and will benefit patients around the world.
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.
On Sept. 11 and 12, nearly 100 researchers from the Ithaca Campus and the Weill Cornell Medicine Campus in New York City came together for the symposium, Metabolic Health: From Molecules to Populations.
The inaugural Flemmie Kittrell Visiting Scholar in the College of Human Ecology, Dr. Ruth C. Browne — president and CEO of Ronald McDonald House New York — will come to campus Oct. 4-6.
A new study helps explain how moving cells respond to environmental cues and set up internal structures that enable them to keep going in one direction during organ development, wound healing, cancer metastasis and many other processes
